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University of Saint-Etienne, Lyon, FranceAbstractCoagulase-negative staphylococci (CNS) cause the majority of post-cataract endophthalmitis, which can lead to anatomical and/or functional
loss of the eye. This study reports the antibiotic susceptibilities of CNS isolates associated with acute post-cataract endophthalmitis cases and
correlates antibiotic resistance with severity and outcome of infection in these patients. Clinical data (initial ocular examination, ﬁnal
prognosis, antibiotic treatment) and the antibiotic susceptibilities of the isolated CNS strains were obtained from 68 patients with post-
surgical endophthalmitis recruited during a 7-year period by the FRench Institutional ENDophthalmitis Study (FRIENDS) group. The CNS
strains displayed 100% susceptibility to vancomycin, 70% to ﬂuoroquinolones, 83% to fosfomycin, 46% to imipenem and 18% to
piperacillin. The most effective antibiotic combinations were fosfomycin plus a ﬂuoroquinolone and imipenem plus a ﬂuoroquinolone,
which were considered adequate in 80% and 58% of patients, respectively. Methicillin resistance was signiﬁcantly associated with older
age (p 0.001), diabetes mellitus (p 0.004), absence of fundus visibility (p 0.06), and poor visual prognosis (p 0.03). Resistance to
ﬂuoroquinolones was signiﬁcantly associated with absence of fundus visibility (p 0.05) and diabetes mellitus (p 0.02). This large
prospective study demonstrates that methicillin resistance and, to a lesser extent, ﬂuoroquinolone resistance in CNS strains causing
postoperative endophthalmitis are both prevalent in France and associated with a poorer visual prognosis. These results emphasize the
need for an effective surveillance of this antibiotic resistance and the development of new diagnostic tools for rapid detection for early
optimization of antibiotic therapy in endophthalmitis patients.
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p://dx.doi.org/10.1016/j.cmi.2015.01.028IntroductionPost-cataract endophthalmitis is a rare, but serious complica-
tion, that can lead to anatomical and/or functional loss of the
eye. Most of these infections are caused by bacterial species of
the skin and by conjunctival and oral commensal ﬂora, espe-
cially coagulase-negative Staphylococcus species [1,2]. Earlyious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Chiquet et al. Antibiotic resistance in acute endophthalmitis 592.e2treatment includes systemic and intravitreal administration of
antibiotics, and in more than half of the cases pars plana vit-
rectomy. Antibiotics are also frequently used for prophylactic
purposes, before eye surgery or during surgery [1]. At the
present time, the choice of prophylactic or therapeutic anti-
microbial agents depends on the microbial epidemiology of
post-cataract endophthalmitis, the antibiotic susceptibilities of
the microorganisms involved, and ﬁnally the pharmacological
and pharmacokinetic characteristics of these antibiotics.
Therefore, optimization of both prevention and treatment of
endophthalmitis includes better characterization of the spec-
trum of microorganisms involved and their susceptibilities to
antimicrobial agents. A useful approach would be the combi-
nation of culture methods and PCR-based techniques [2,3] so
as to detect emerging pathogens and/or antimicrobial resis-
tance, particularly resistance to antibiotics currently used in
endophthalmitis strategies. The emergence of resistant micro-
organisms has been reported in endophthalmitis patients in the
USA and India [4–7]. Coagulase-negative staphylococci (CNS)
are involved in 33–70% of culture-positive post-cataract
endophthalmitis cases [3,4,6,8]. We recently reported that 9%
of patients with CNS endophthalmitis have a poor ocular
prognosis (visual acuity <20/100) [9]. Severe CNS infections
may occur because of speciﬁc virulence traits of the strains
involved, such as higher adhesion or bioﬁlm formation [10] and/
or acquired antibiotic resistance [11], decreasing the effec-
tiveness of local and systemic antibiotic therapies. New data are
needed to characterize the prevalence of antibiotic resistance
among the CNS population responsible for acute endoph-
thalmitis, especially in Europe where recent data are lacking.
Microbiological and clinical data obtained for postsurgical
endophthalmitis cases recruited during a 7-year period were
previously published by the FRench Institutional ENDoph-
thalmitis Study (FRIENDS) group [2,3,9,12]. Among them, 68
patients developed acute post-cataract endophthalmitis caused
by CNS species. The main objective of the present study was to
evaluate the in vitro susceptibilities of the CNS isolates obtained
from intraocular samples collected in these patients. The sec-
ondary objectives were to assess whether the results with
routine curative and preventive antibiotic treatments were
adequate and to tentatively correlate antibiotic susceptibility
data with the initial clinical presentation and ﬁnal visual and
anatomical outcome in these patients.Materials and methodsPatients
This prospective study included 68 post-cataract surgery
endophthalmitis cases (68 eyes) infected with a CNS speciesClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inbetween March 2004 and December 2011 in three French
university hospitals (Grenoble, Lyon, Saint-Etienne) belonging
to the FRIENDS group.
The study followed the Declaration of Helsinki guidelines for
research involving human participants and was approved by the
local Institutional Review Board (IRB# 5921). The data sheet,
sampling techniques and microbiological procedures, antibiotics
used for intravitreal injections, and follow-up visits were stan-
dardized in the three centres [3]. The therapy strategy (mainly
the requirement for and timing of a pars plana vitrectomy) was
left to the discretion of each surgeon.
Acute endophthalmitis was diagnosed on the basis of clinical
features, including decreased vision, periocular pain, and ante-
rior and posterior segment inﬂammation. A baseline evaluation
form was completed during the initial examination of each pa-
tient and included demographic features, past medical history,
ocular history, details of cataract surgery and data of the initial
ocular examination. The ﬁnal prognosis was deﬁned at the 6-
month visit.
On admission, an immediate tap of aqueous humor (AH)
and/or vitreous was performed followed by intravitreal injec-
tion of vancomycin (1 mg) and ceftazidime (2.25 mg). Patients
were also treated with a broad-spectrum intravenous antibiotic
regimen (ciproﬂoxacin, oﬂoxacin, levoﬂoxacin, or
fosfomycin + piperacillin or imipenem) for 5 days and topical
drugs (corticosteroids, tropicamide).
All eyes were sampled after two instillations of 5% aqueous
povidone iodine solution in the conjunctival sac. AH
(150–200 μL) and/or vitreous samples (200–300 μL) were
collected just before the intravitreal injection of antibiotics.
Undiluted vitreous samples (500 μL) were also collected during
pars plana vitrectomy. Ocular specimens were separated into
two samples at the time of sampling under aseptic conditions
and one half was directly injected into brain–heart infusion
broth (AES Laboratories, Combourg, France, from 2004 to
2007) or into a paediatric blood culture bottle (Becton Dick-
inson, Pont-de-Claix, France, from 2008 to 2011) and then
rapidly sent to the microbiology laboratory for conventional
cultures. The other half was stored in a DNA-free micro-
centrifuge tube for PCR and transferred to a single hospital
centre.
CNS strains and antibiotic susceptibility testing
Strains of CNS were isolated from intraocular samples
collected from endophthalmitis patients at the time of hospi-
talization. Culture-positive samples included aqueous humor
(33.8%) and vitreous (66.2%) obtained by tap or vitrectomy.
CNS strains were identiﬁed using conventional phenotypic
methods and conﬁrmed by PCR ampliﬁcation and sequencing of
a portion of the tuf gene, as previously described [13]. The CNSfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 592.e1–592.e8
592.e3 Clinical Microbiology and Infection, Volume 21 Number 6, June 2015 CMIspecies distribution was as follows: Staphylococcus epidermidis
(56 strains, 82.4%), Staphylococcus lugdunensis (n = 5), S. warneri
(n = 3), Staphylococcus hominis (n = 1), Staphylococcus haemoly-
ticus (n = 2) and Staphylococcus saprophyticus (n = 1).
The antibiotic susceptibilities of the CNS strains were eval-
uated using the Vitek II automated system in the Grenoble and
Saint-Etienne hospitals (bioMérieux, Marcy l’Etoile, France) or
the Phoenix system in the Lyon hospital (Becton Dickinson,
Pont-de-Claix, France). The results were interpreted in all cases
according to the French National Antibiogram Committee
Guidelines (CA-SFM 2010; http://www.sfm-microbiologie.org).
The antibiotics tested were penicillin G, oxacillin, kanamycin,
tobramycin, gentamicin, erythromycin, clindamycin, pristina-
mycin, doxycycline, fusidic acid, cotrimoxazole, rifampicin,
vancomycin, teicoplanin, linezolid and ﬂuoroquinolones. The
group of ﬂuoroquinolones comprised oﬂoxacin or levoﬂoxacin,
depending on the automated system used. Susceptibility to
cefuroxime and moxiﬂoxacin were determined using the CA-
SFM expertise rules.
Adequacy of the systemic antibiotic therapies
Because all patients received intraocular vancomycin, and no
acquired resistance to this antibiotic was found in isolated CNS
strains, we only evaluated the adequacy of the systemic anti-
biotic therapy. The systemic treatment was considered
adequate if the bacterial strain was susceptible to the two an-
tibiotics administered, and partially adequate if the strain was
susceptible to one antibiotic.
Statistical correlation between clinical and antibiotic
susceptibility data
Statistical analysis was performed using the SPPS 17.0 software
(SPSS for Windows, Chicago, IL, USA). Comparisons between
groups were done using the non-parametric Wilcoxon test.
The relationships between qualitative data were studied using a
chi-square test. Signiﬁcance was accepted for a p-value <0.05.ResultsClinical data at baseline and at the 6-month follow up
The population studied had a sex ratio of 0.79 (30 male, 38
female) and a mean age of 76.2 ± 11.4 years. Systemic risk
factors for endophthalmitis were diabetes mellitus (18%) and
immunosuppression (7%). The left eye was involved in 56% of
the cases. There was no statistically signiﬁcant seasonal pre-
dominance of eye infections, with 33% of cases occurring in
spring, 12% in summer, 25% in autumn, and 30% in winter. The
delay of ocular symptoms after cataract surgery was on average
4.3 ± 2.7 days. The main symptoms were pain (70% of cases)Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectand decreased visual acuity (100%), which was categorized as
follows: >20/400 in 12% of the patients, ﬁnger counting in 14%,
hand motions in 33%, light perception in 40% and no light
perception in 1%. Clinical signs at presentation were eyelid
oedema (20%), corneal oedema (58%), hypopyon (88%) and
absence of fundus visibility (83%). The mean intraocular pres-
sure was 15.5 ± 7.4 mmHg.
None of the patients received an antibiotic prophylaxis at the
time of cataract surgery. At the time of endophthalmitis diag-
nosis, all patients received a systemic antibiotic therapy con-
sisting of one of the four following combinations: piperacillin
plus a ﬂuoroquinolone (levoﬂoxacin, oﬂoxacin or ciproﬂoxacin)
in 66% of the cases; piperacillin plus fosfomycin in 2%; fosfo-
mycin plus a ﬂuoroquinolone (levoﬂoxacin, ciproﬂoxacin) in
12%; and imipenem plus a ﬂuoroquinolone (levoﬂoxacin) in
20%. All patients also had an intravitreous injection of antibi-
otics (vancomycin plus ceftazidime). A pars plana vitrectomy
was performed in 49 of the 68 eyes (72%), within a mean
3.6 ± 2.2 days after presentation. Steroids were not injected at
the time of the ﬁrst intravitreous injection but were injected at
the end of the pars plana vitrectomy in 36 out the 49 patients
(73%).
Antibiotic susceptibility of CNS strains
Susceptibility rates >90% were found for vancomycin, pristi-
namycin, rifampicin and linezolid. Lower susceptibility rates
(between 70% and 85%) were found in decreasing order for
cotrimoxazole, clindamycin, gentamicin, doxycycline, fusidic
acid, tobramycin, ﬂuoroquinolones and teicoplanin (Fig. 1).
Methicillin susceptibility (susceptibility to oxacillin) was found
for 55% of the CNS strains tested. The same susceptibility rate
was found for erythromycin.
Adequacy of the systemic antibiotic therapies
The ﬂuoroquinolones disclosed the highest in vitro activity
against CNS strains, with 70% susceptibility of CNS. Bacterial
susceptibility to fosfomycin, imipenem and piperacillin treat-
ments was 83%, 46% and 18%, respectively. When considering
the different combinations of two antibiotics used for systemic
antibiotic therapy (n = 68), treatment was considered adequate
in 38% of the cases, partially adequate in 35% and inadequate in
26%. The most effective combination therapies were
fosfomycin + ﬂuoroquinolone (adequate in 80%) and
imipenem + ﬂuoroquinolone (58%).
Correlation between resistance patterns and clinical
data
The ﬁnal visual prognosis (at the 6-month visit) was deﬁned as
good (20/40) or poor (<20/40) in 64.5% and 35.5% of the 68
cases, respectively. Methicillin resistance was signiﬁcantlyious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 592.e1–592.e8
FIG. 1. Antibiotic resistance of coagulase-negative staphylococci from post-cataract endophthalmitis. R, resistant; I, intermediate; S, susceptible. The
number of bacterial strains tested is indicated for each antibiotic.
CMI Chiquet et al. Antibiotic resistance in acute endophthalmitis 592.e4associated with age (81 ± 8 versus 72 ± 13 years, p 0.001),
diabetes mellitus (meti-R 83% versus 36% in the non-diabetic
population, p 0.004), absence of fundus visibility (meti-R 51%
versus 23%, p 0.06) and visual prognosis (55% in the poor VA
group versus 29%, p 0.03).
Fluoroquinolone resistance was signiﬁcantly associated with
absence of fundus visibility (22% versus 0%, p 0.05) and diabetes
mellitus (36% versus 13%, p 0.02), whereas statistically non-
signiﬁcant differences were found for the association of this
resistance and hypopyon (21% versus 0%, p 0.09) or visual
prognosis (23% versus 8.3%, p 0.1).DiscussionThis is the ﬁrst European study on the prevalence of antibiotic
resistance in CNS strains infecting a large series of patients with
acute post-cataract endophthalmitis. All previously published
studies were conducted in the USA [4,6,7,14,15] or India [16].
Our case series was highly homogeneous for the microorgan-
isms involved (CNS strains, including 82.4% S. epidermidis), the
type of surgery (cataract), and the absence of cefuroxime
prophylaxis. The predominance of S. epidermidis strains was
expected because microorganisms causing postoperative
endophthalmitis mainly belong to the patients’ commensal ﬂora
of the conjunctiva [7,17] No acquired resistance to vancomycin
was found, and this antibiotic remains the reference treatment
for CNS infections. In contrast, we found a high prevalence of
resistance to β-lactams and ﬂuoroquinolones, which are the
antibiotic classes most frequently used for prophylaxis and
treatment of these nosocomial infections. Most particularly,Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inmethicillin-resistance involved 45% of the CNS strains, which is
comparable to the 56% and 52% rates previously reported for
endophthalmitis (8) and normal conjunctival samples [17–22],
respectively (Tables 1 and 2). A recent retrospective study
showed a continuous increase of methicillin resistance in
endophthalmitis isolates of S. epidermidis from 31% to 55%
during a 25-year period.
Fluoroquinolone resistance was found in 30% of CNS strains
and 89% of the methicillin-resistant CNS strains. This is in
accordance with previous reports highlighting that both types
of resistance are often combined [23]. An increase in ﬂuo-
roquinolone resistance rate in the normal conjunctival ﬂora was
reported between 2003 and 2011, and after repeated use of
topical antibiotics [18,24–27]. For endophthalmitis patients,
Benz et al. [7] reported a resistance rate of 54% for levo-
ﬂoxacin, but also noted a signiﬁcant increase in the prevalence
of this type of resistance between 2001 and 2006.
The present results show that the CNS strains involved were
often resistant to the administered β-lactam and ﬂuo-
roquinolone compound, with 80% resistance rates for penicillin
G, 45% for oxacillin (methicillin resistance) and 30% for the
ﬂuoroquinolone compounds oﬂoxacin and levoﬂoxacin.
Therefore, for CNS-related endophthalmitis caused by
methicillin-susceptible strains of CNS, piperacillin (which is no
more effective than penicillin G against CNS) should be
replaced with a β-lactam with a lower resistance rate and
effective intraocular penetration such as imipenem. For
methicillin-resistant strains, non-β-lactam antibiotics such as
fosfomycin and ﬂuoroquinolones should be considered. How-
ever, these two antibiotics should not be used alone because of
the high risk of resistant mutant selection. Apart from in vitrofectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 592.e1–592.e8
TABLE 1. Review of main studies of antibiotic sensitivity from bacteria of the normal conjunctiva
Ta et al. [18]
Mino de
Kaspar
et al. [19]
Hori
et al. [38]
Hori
et al. [37] Ta et al. [20]
Park
et al. [27]
Fernandez-
Rubio et al. [22]
Kim
et al. [39]
Kim
et al. [39]
Moss
et al. [21]
Kim
et al. [25]
Kim
et al. [26]
Dave
et al. [24]
Hsu
et al. [17]
Year 2003 2005 2008 2009 2009 2009 2009 2010 2010 2010 2011 2011 2011 2013
n n [ 112 n [ 124 n [ 62 n [ 58 n [ 95 n [ 263 n [ 707 n [ 8 n [ 27 n [ 59 n [ 70 n [ 133 n [ 58 n [ 127
Species CNS CNS CNS CNS CNS CNS CNS S. aureus S. epidermidis CNS CNS CNS S. epidermidis S. epidermidis
Penicillin G 10% 18% 20% 12% 5% 14%
Oxacillin 59% 65% 48% 62% 55% 51% 50% 60% 54%
Kanamycin 99% 96% 100% 99%
Tobramycin 96% 94% 99% 87%
Gentamicin 99% 92% 98% 85% 100% 100% 90% 100% 100% 100% 94%
Erythromycin 51% 55% 50% 44% 38% 37% 50% 36% 41% 35% 49%
Clindamycin 88% 100% 93% 86% 90% 76%
Pristinamycin
Doxycyclin 69% 81% 100% 100% 80% 94% 98%
Ciproﬂoxacin 78% 77% 70% 69% 74% 50%
Oﬂoxacin 78% 75% 70% 88% 48% 36% 41% 35%
Levoﬂoxacin 92% 86% 61% 60% 76% 79% 84% 88% 52% 55% 36% 41% 35%
Moxiﬂoxacin 97% 62% 85% 90% 88% 63% 70% 54% 57% 60%
Gatiﬂoxacin 96% 73% 60% 86% 91% 88% 67% 70% 59% 61% 60%
Fusidic acid 99%
Rifampicin 100% 100% 100% 100% 100% 100%
Fosfomycin 87%
Teicoplanin 100%
Vancomycin 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
Linezolid 100% 96% 100% 99% 100%
CNS, coagulase-negative staphylococci; n, number of bacterial strains; S. aureus, Staphylococcus aureus; S. epidermidis, Staphylococcus epidermidis.
Results of sensitivity are expressed as % of sensitivity.
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TABLE 2. Review of the main studies of antibiotic sensitivity from bacteria involved in endophthalmitis
Kunimoto et al. [40] Benz et al. [7] Recchia et al. [6] Deramo et al. [5] Miller et al. [41] Harper et al. [4] Schimel et al. [42]
Year 1999 2004 2005 2006 2006 2007 2012
n n [ 45 n [ 87 n [ 96 n [ 9 n [ 111 n [ 59 n [ 89
Species CNS S. epidermidis CNS CNS CNS CNS CNS
Oxacillin 44.0%
Cefazolin 93.2% 48.0% 60.0%
Amikacin 89.5%
Gentamicin 81.8% 72.0%
Ciproﬂoxacin 88.4% 59.0% 62.0% 67.0% 66% 84% 40%
Levoﬂoxacin 55.0% 55.5% 69% 42%
Moxiﬂoxacin 72% 48.00% 42%
Chloramphenicol 88.6%
Vancomycin 86.8% 100.0% 100.0% 100.0% 100% 100%
Linezolid 100%
Abbreviations: CNS, coagulase-negative staphylococci; S. epidermidis, Staphylococcus epidermidis.
CMI Chiquet et al. Antibiotic resistance in acute endophthalmitis 592.e6susceptibility data, the pharmacokinetic properties of antibiotics
within the eye tissues should be evaluated. Intravitreous con-
centrations higher than the MICs of the ﬂuoroquinolone-
susceptible CNS strains have been reported after oral or
intravenous administration of moxiﬂoxacin [28], gatiﬂoxacin
[29] and to a lesser extent ciproﬂoxacin [30] and levoﬂoxacin
[31]. The intravitreous injection of a ﬂuoroquinolone could also
be considered as an alternative in the local treatment of CNS
endophthalmitis because these antibiotics have no retinal
toxicity, have favourable pharmacokinetic properties after
intravitreous injection [32], can be combined with vancomycin
[33] and are effective in animal models [34].
A secondary objective of this study was to assess the po-
tential efﬁcacy of cefuroxime antibiotic prophylaxis to prevent
postoperative endophthalmitis. This antibiotic prophylaxis is
generalized at this time because of its reported efﬁcacy in a few
studies, including a randomized controlled study [35] and the
recent commercialization of a cefuroxime preparation that can
be used for intracameral injection (Aprokam®; Thea, Clermont-
Ferrand, France). We found that 55% of the CNS strains in our
series were resistant to methicillin, which implies resistance to
almost all the β-lactams currently available. One issue is
therefore the true efﬁcacy of intracameral injection of cefur-
oxime in patients infected with a methicillin-resistant strain of
CNS. As stated by Montan et al. [36] the median aqueous hu-
mor concentration of cefuroxime 30 s after intracameral in-
jection was 2742 mg/L, decreasing to 756 mg/L 1 h later. Two
questions remain to be solved: ﬁrst, what are the cefuroxime
concentrations in aqueous humor during the ﬁrst 12 h following
intracameral injection; and second, are these concentrations
efﬁcient on methicillin-resistant CNS strains?
We studied for the ﬁrst time the relationship between clinical
data and methicillin or ﬂuoroquinolone resistance in CNS-
related endophthalmitis. Clinical factors associated withClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inmethicillin resistance (diabetes, fundus visibility) in this study are
well-known prognostic factors [9]. We previously showed that
9% of CNS-related endophthalmitis cases carried a poor visual
prognosis, despite the usual low virulence associated with these
bacteria [9]. One hypothesis that remains to be demonstrated
could be a relationship between methicillin resistance and
virulence. In our study, methicillin resistance has never been
associated with resistance to vancomycin, suggesting that
intravitreous injection of the latter antibiotic remains theoreti-
cally effective. Another cause of intravitreal antibiotic failure may
be the poorly characterized pharmacokinetic and pharmacody-
namic properties of vancomycin and ceftazidime in the eye tis-
sues after intravitreal injection and the variability of antibiotic
diffusion in the vitreous secondary to the organization of the
inﬂammatory vitreous. For example, antibiotic exposure (van-
comycin or gentamicin) for less than 2 h may not be adequate to
eliminate all microorganisms involved in endophthalmitis. These
data highlight that the efﬁcacy of intravitreal antibiotics may be
related to many factors, including the resistance pattern.
In conclusion, this large prospective study evaluating the
antibiotic susceptibility of CNS strains involved in postoperative
endophthalmitis cases demonstrates that methicillin resistance
and to a lesser extent resistance to ﬂuoroquinolones are of
major concern in France. Given the regional speciﬁcities of
antibiotic resistance, studies are needed in different countries to
analyse the balance between current prophylactic and thera-
peutic strategies and the observed antibiotic resistance. The high
rates of resistance to β-lactams and ﬂuoroquinolones found in
this CNS series emphasize the need for European microbial
surveillance and new diagnostic tools, especially molecular
methods [3] for rapid identiﬁcation of antibiotic resistance in the
microorganisms involved. This will allow early optimization of
antibiotic therapy in endophthalmitis patients and possibly
improvement of endophthalmitis patient prognosis [38–41].fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 592.e1–592.e8
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